AVAPAG 20 mg (Avatrombopag) Tablets

AVAPAG 20 mg (Avatrombopag) is a thrombopoietin receptor agonist that helps stimulate platelet production in the bone marrow. It is primarily used to increase platelet counts in adults with thrombocytopenia, reducing the risk of bleeding complications associated with low platelet levels.

Key Therapeutic Uses:

• Management of thrombocytopenia in adults with chronic liver disease scheduled for medical or surgical procedures.
• Treatment of chronic immune thrombocytopenia (ITP) in patients who have had an insufficient response to previous therapies.
• Supports the body's natural platelet production process.
• Helps reduce the need for platelet transfusions in eligible patients.
• Assists in maintaining adequate platelet levels to minimize bleeding risks.
• Improves platelet count control in selected hematology patients under medical supervision.

Generic Name: Avatrombopag

Active Ingredient:

• Each film-coated tablet contains Avatrombopag Maleate equivalent to Avatrombopag 20 mg.

Inactive Ingredients:

• Film-coating agents
• Tablet excipients
• Stabilizing and binding agents

The complete list of inactive ingredients may vary depending on the product formulation.

Important: Dosage should be determined by a qualified healthcare professional based on the patient's condition, platelet count, and treatment goals.

Administration Guidelines:

• Take orally as prescribed by your physician.
• Tablets should be swallowed whole with water.
• May be taken with food according to prescribing recommendations.
• Do not crush, chew, or split the tablet unless advised by a healthcare provider.
• Follow the prescribed treatment schedule carefully to achieve optimal platelet response.

For Chronic Liver Disease Patients:

• Treatment is generally initiated prior to a scheduled medical procedure based on baseline platelet counts and physician assessment.

For Chronic Immune Thrombocytopenia (ITP):

• The dose may be adjusted according to platelet response and clinical monitoring.
• Regular platelet count monitoring is recommended during treatment.

Missed Dose:

• If a dose is missed, take it as soon as remembered unless it is almost time for the next dose.
• Do not take two doses at the same time to make up for a missed dose.

Monitoring Requirements:

• Routine platelet count assessments.
• Periodic evaluation of treatment response.
• Monitoring for adverse reactions and thrombotic events when clinically indicated.

Always use AVAPAG 20 mg exactly as directed by your healthcare provider.